Detalhe da pesquisa
1.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol
; 24(7): 783-797, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414011